AI Trend Insights
Evidence-led trend reports that connect public signals to practical tools and product decisions.
finance decision
WSFS Financial Corporation Posts Higher Year-Over-Year Diluted EPS and Net Income for Both the Quarter and the Six-Month Year-to-Date Period
WSFS FINANCIAL CORP filed the periodic report summarised below from its SEC evidence. Net Income (Loss) Attributable to Parent was $171,225,000 for the six months ended June 30, 2026, up from $138,222,000 a year earlier. Earnings Per Share, Diluted was $3.26 per diluted share for the six months ended June 30, 2026, up from $2.39 per diluted share a year earlier. APIC, Share-based Payment Arrangement, Increase for Cost Recognition was $7,108,000 for the six months ended June 30, 2026, up from $6,327,000 a year earlier. Net Cash Provided by (Used in) Financing Activities was $1,190,631,000 for the six months ended June 30, 2026, up from -$143,015,000 a year earlier.
finance decision
Microchip Technology Posts Higher Revenue, Operating Income, and a Return to Profitability Versus Prior-Year Quarter
MICROCHIP TECHNOLOGY INC filed the periodic report summarised below from its SEC evidence. Net Income (Loss) Attributable to Parent was $229,800,000 for the three months ended June 30, 2026, up from -$18,600,000 a year earlier, swinging from a prior-year loss to a profit. Earnings Per Share, Diluted was $0.37 per diluted share for the three months ended June 30, 2026, up from -$0.09 per diluted share a year earlier, swinging from a prior-year loss to a profit. Revenue from Contract with Customer, Excluding Assessed Tax was $1,484,700,000 for the three months ended June 30, 2026, up from $1,075,500,000 a year earlier. Operating Income (Loss) was $336,800,000 for the three months ended June 30, 2026, up from $32,100,000 a year earlier.
finance decision
Orrstown Financial Services Reports Higher Year-Over-Year Diluted EPS and Net Income for Both the Quarter and the Six-Month Year-to-Date Window
ORRSTOWN FINANCIAL SERVICES INC filed the periodic report summarised below from its SEC evidence. Net Income (Loss) Attributable to Parent was $42,967,000 for the six months ended June 30, 2026, up from $37,499,000 a year earlier. Earnings Per Share, Diluted was $2.21 per diluted share for the six months ended June 30, 2026, up from $1.94 per diluted share a year earlier. Accretion (Amortization) of Discounts and Premiums, Investments was $9,318,000 for the six months ended June 30, 2026, down from $11,949,000 a year earlier. Net Cash Provided by (Used in) Financing Activities was $31,360,000 for the six months ended June 30, 2026, up from -$92,239,000 a year earlier.
finance decision
Heron Therapeutics interim report shows every reported income line in the red, with the half-year profit-to-loss swing as the binding signal
HERON THERAPEUTICS, INC. /DE/ filed the periodic report summarised below from its SEC evidence. Net Income (Loss) Attributable to Parent was -$13,600,000 for the six months ended June 30, 2026, down from $254,000 a year earlier, swinging from a prior-year profit to a loss. Operating Income (Loss) was -$6,809,000 for the six months ended June 30, 2026, down from $1,517,000 a year earlier, swinging from a prior-year profit to a loss. Earnings Per Share, Diluted was -$0.07 per diluted share for the six months ended June 30, 2026, down from $0 per diluted share a year earlier, swinging from a prior-year profit to a loss.
finance decision
Perspective Therapeutics widens loss on every reported line in the latest interim filing
Perspective Therapeutics, Inc. filed the periodic report summarised below from its SEC evidence. Net Income (Loss) Attributable to Parent was -$52,975,000 for the six months ended June 30, 2026, down from -$39,662,000 a year earlier. Operating Income (Loss) was -$57,539,000 for the six months ended June 30, 2026, down from -$45,871,000 a year earlier. Earnings Per Share, Diluted was -$0.47 per diluted share for the six months ended June 30, 2026, up from -$0.54 per diluted share a year earlier. Net Cash Provided by (Used in) Financing Activities was $164,511,000 for the six months ended June 30, 2026, up from $10,105,000 a year earlier. Net Cash Provided by (Used in) Investing Activities was -$94,534,000 for the six months ended June 30, 2026, down from -$1,301,000 a year earlier.
finance decision
L.B. Foster posts higher year-to-date and quarterly profit; quarter-level operating income softens despite a profit-to-profit transition
FOSTER L B CO filed the periodic report summarised below from its SEC evidence. Net Income (Loss) Attributable to Parent was $4,612,000 for the six months ended June 30, 2026, up from $775,000 a year earlier. Operating Income (Loss) was $8,196,000 for the six months ended June 30, 2026, up from $5,755,000 a year earlier. Earnings Per Share, Diluted was $0.44 per diluted share for the six months ended June 30, 2026, up from $0.07 per diluted share a year earlier. Net Cash Provided by (Used in) Financing Activities was $605,000 for the six months ended June 30, 2026, down from $22,468,000 a year earlier. Net Cash Provided by (Used in) Investing Activities was -$6,521,000 for the six months ended June 30, 2026, down from -$5,199,000 a year earlier.
finance decision
Telos Posts Loss-to-Profit Swing on Higher Revenue Across Both Reported Windows
TELOS CORP filed the periodic report summarised below from its SEC evidence. Net Income (Loss) Attributable to Parent was $2,683,000 for the six months ended June 30, 2026, up from -$18,121,000 a year earlier, swinging from a prior-year loss to a profit. Operating Income (Loss) was $1,765,000 for the six months ended June 30, 2026, up from -$18,905,000 a year earlier, swinging from a prior-year loss to a profit. Earnings Per Share, Diluted was $0.03 per diluted share for the six months ended June 30, 2026, up from -$0.25 per diluted share a year earlier, swinging from a prior-year loss to a profit.
finance decision
Gencor Industries Quarterly Report Shows Mixed Year-Over-Year Profitability Trends
GENCOR INDUSTRIES INC filed the periodic report summarised below from its SEC evidence. Net Income (Loss) Attributable to Parent was $12,965,000 for the nine months ended June 30, 2026, down from $13,740,000 a year earlier. Operating Income (Loss) was $13,137,000 for the nine months ended June 30, 2026, down from $14,241,000 a year earlier. Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities was -$11,596,000 for the nine months ended June 30, 2026, down from -$10,397,000 a year earlier. Net Cash Provided by (Used in) Investing Activities was -$1,698,000 for the nine months ended June 30, 2026, down from -$951,000 a year earlier.
finance decision
American Vanguard posts wider parent-level loss on both reported windows as revenue contracts and the quarter swings from operating profit to operating loss
AMERICAN VANGUARD CORP filed the periodic report summarised below from its SEC evidence. Operating Income (Loss) was -$303,000 for the three months ended June 30, 2026, down from $4,366,000 a year earlier, swinging from a prior-year profit to a loss. Revenue from Contract with Customer, Excluding Assessed Tax was $240,322,000 for the six months ended June 30, 2026, down from $245,113,000 a year earlier. Net Income (Loss) Attributable to Parent was -$14,014,000 for the six months ended June 30, 2026, down from -$9,311,000 a year earlier. Earnings Per Share, Diluted was -$0.49 per diluted share for the six months ended June 30, 2026, down from -$0.33 per diluted share a year earlier.
finance decision
Investors Title Company Posts Higher Year-to-Date Profit and Revenue, With Quarterly Revenue Lines Splitting Direction
INVESTORS TITLE CO filed the periodic report summarised below from its SEC evidence. Revenue from Contract with Customer, Excluding Assessed Tax was $20,482,000 for the six months ended June 30, 2026, up from $19,672,000 a year earlier. Revenues was $150,516,000 for the six months ended June 30, 2026, up from $130,214,000 a year earlier. Net Income (Loss) Attributable to Parent was $20,700,000 for the six months ended June 30, 2026, up from $15,449,000 a year earlier. Earnings Per Share, Diluted was $10.93 per diluted share for the six months ended June 30, 2026, up from $8.16 per diluted share a year earlier. Accretion (Amortization) of Discounts and Premiums, Investments was $708,000 for the six months ended June 30, 2026, down from $733,000 a year earlier.